Catalyst Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
483.82 |
560.69 |
616.15 |
680.84 |
773.90 |
856.35 |
| Przychód Δ r/r |
0.00% |
15.89% |
9.89% |
10.50% |
13.67% |
10.65% |
| Przychód (min) |
481.52 |
530.40 |
577.44 |
680.84 |
739.16 |
817.90 |
| Przychód (max) |
485.93 |
615.97 |
653.50 |
680.84 |
817.85 |
904.97 |
| EBITDA (średnia) |
190.48 |
220.74 |
242.58 |
268.04 |
304.68 |
337.14 |
| EBIT (średnia) |
173.33 |
200.87 |
220.74 |
243.91 |
277.25 |
306.79 |
| EBIT % |
35.83% |
35.83% |
35.83% |
35.83% |
35.83% |
35.83% |
| Zysk netto (średni) |
150.78 |
186.92 |
236.99 |
253.45 |
261.97 |
294.03 |
| Zysk netto % |
31.16% |
33.34% |
38.46% |
37.23% |
33.85% |
34.34% |
| EPS (średnia) |
1.22 |
1.50 |
1.76 |
1.85 |
2.10 |
2.35 |
| Liczba analityków (Przychody) |
7 |
6 |
7 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
5 |
4 |
4 |
3 |
1 |
1 |
| symbol |
CPRX |
CPRX |
CPRX |
CPRX |
CPRX |
CPRX |